Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
Running, not enrolling
Conditions studied: Prostate Carcinoma
In brief
The goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the patients / volunteers.
Key facts
- Study ID
- NCT04788277
- Run by
- Thomas Jefferson University
- People needed
- 810
- Starts
- 2020-02-26
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-06-30
Who can join
Age: 50 and older, up to 79. Sex: male. Healthy volunteers: accepted.
Where it is running
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.